Steve Derr

Associate Director, Access and Reimbursement, Rare Disease (Interstitial Lung Disease Biosimilars) @Boehringer Ingelheim

GB

Optimize access and reimbursement for the orphan drug OFEV and Humira biosimilar CYLTEZO by monitoring trends of Payment Organizations through case management activities, supporting internal and external stakeholders including Payer/Field Sales Teams • Collaborate with top institutions including; Johns Hopkins Hospital, Temple Health, and The University of Pennsylvania Interstitial Lung Disease Clinics • Communicate compliantly and effectively to Specialty Pharmacy Liaisons to optimize…